Back to Journals » OncoTargets and Therapy

SJR OA
CiteScore
Impact Factor

OncoTargets and Therapy

ISSN: 1178-6930


       

Editor-in-Chief: Professor Gaetano Romano

OncoTargets and Therapy is an international, peer-reviewed journal focusing on the molecular diagnosis of and targeted molecular or precision therapy for all types of cancer. This journal explores the evidence behind new and existing therapies to aid their informed acceptance by clinicians and treatment adherence by patients.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Articles:

Latest articles:

- 5 records -

Original Research

Identification and Validation of Nicotinamide Metabolism-Related Gene Signatures as a Novel Prognostic Model for Hepatocellular Carcinoma

Yang S, Li A, Lv L, Duan J, Zheng Z, Zhuo W, Min J, Wei J

OncoTargets and Therapy 2024, 17:423-438

Published Date: 28 May 2024

Case report

Scalp Metastasis After Breast Cancer Surgery: A Case Report

Wu J, Zhang W, Zhang H, Lu X, Luan B, Yang Q, Chen L, Chen W, Ge F

OncoTargets and Therapy 2024, 17:411-419

Published Date: 23 May 2024

Original Research

Testosterone Exacerbates the Formation of Liver Cancer Induced by Environmental N-Nitrosamines Exposure: Potential Mechanisms and Implications for Human Health

Yin X, Gu HW, Ning D, Li YS, Tang HB

OncoTargets and Therapy 2024, 17:395-409

Published Date: 17 May 2024

Review

Evaluating the Therapeutic Potential of Durvalumab in Adults with Locally Advanced or Metastatic Biliary Tract Cancer: Evidence to Date

Storandt MH, Jin Z, Mahipal A

OncoTargets and Therapy 2024, 17:383-394

Published Date: 17 May 2024

Original Research

MCM5 is a Novel Therapeutic Target for Glioblastoma

Zhou J, Zheng H, Zhang H, Yu W, Li B, Ye L, Wang L

OncoTargets and Therapy 2024, 17:371-381

Published Date: 13 May 2024


Read more articles